Relevant markers include malondialdehyde (MDA), 8-isoprostane, reduced glutathione (GSH), and high-sensitivity CRP
By enhancing the secretion of insulin in response to elevated blood glucose levels, delaying gastric emptying, and reducing glucagon secretion, Semaglutide effectively lowers blood sugar levels in patients with type 2 diabetes
Most people use GLP-1 medications for 12-24 months to achieve and stabilize their weight loss, making long-term costs crucial to consider
Some also continue certain supplements afterward as part of their long-term routine
In February 2026, the FDA restricted GLP-1 APIs in non-approved compounded products, tightening enforcement in one area while, at the same time, Kennedys announcement committed to loosening access across 14 others